Evaluating smoking cessation interventions for PWH in South Africa: Efficacy, implementation, and cost-effectiveness.
评估南非艾滋病毒感染者戒烟干预措施:功效、实施和成本效益。
基本信息
- 批准号:10269650
- 负责人:
- 金额:$ 67.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-15 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:AbstinenceAddressAdoptionAdultAgeBehavioralBiochemicalCarbon MonoxideCardiovascular DiseasesCaringCause of DeathChronic Obstructive Airway DiseaseCigaretteClinicClinicalClinical Practice GuidelineClinical TrialsCost effectiveness researchCotinineCounselingDataDevelopmentEffectivenessEnrollmentEpidemiologistEvidence based interventionExhalationGenderGoalsGuidelinesHIVHIV/TBHomeIncidenceInfrastructureInterventionLungMaintenanceMalignant NeoplasmsMeasuresMediator of activation proteinMotivationOutcomePF4 GeneParticipantPatient Self-ReportPatientsPhasePoliciesPopulationPrevalencePsychologistRandomizedRandomized Controlled TrialsReach, Effectiveness, Adoption, Implementation, and MaintenanceResearchResourcesRisk FactorsScientistSelf EfficacySmokeSmokerSmokingSmoking Cessation InterventionSouth AfricaSouth AfricanStressTarget PopulationsTimeTobacco Use CessationTobacco smoking behaviorTuberculosisUrineVariantWomanWorkantiretroviral therapyarmbasebudget impactcomorbiditycontrol trialcostcost effectivecost effectivenesscravingdesigneffective interventioneffectiveness implementation studyefficacy evaluationepidemiology studyevidence basehealth related quality of lifehigh riskimplementation costimplementation determinantsimplementation fidelityimplementation researchintervention effectmennicotine cravingnicotine gumnicotine patchnicotine replacementpatient screeningpeerpeer supportperi-urbanprimary care settingprimary outcomeprogramspublic health relevancescale upscreeningsecondary outcomeservice deliverysmoking abstinencesmoking cessationsmoking initiationsmoking prevalencesmoking-related diseasesocialstressorsuccesstherapy developmenttobacco screeningtreatment optimizationtreatment strategyurban settingvarenicline
项目摘要
PROJECT SUMMARY/ABSTRACT
The purpose of this project is to optimize a smoking cessation program for PWH in South Africa by evaluating
the efficacy, implementation, and cost-effectiveness of evidence-based smoking cessation interventions with
demonstrated success in other low-resource settings. South Africa is home to 7.5 million people with HIV (PWH),
nearly 20% of the global burden. South Africa also has one of the highest annual tuberculosis (TB) incidences
globally (520/100,000) and an increasing burden of cardiovascular disease and chronic obstructive pulmonary
disease (COPD). Smoking is a risk factor for TB, the leading cause of death among PWH. Further, PWH are at
high risk for other smoking-related diseases, including cardiovascular disease and pulmonary comorbidities in
addition to TB. In South Africa, tobacco smoking is prolific; we have found 52% of men and 13% of women with
HIV to be current smokers. South African policy supports screening for smoking and smoking cessation efforts
for PWH; these are included in the South African National antiretroviral therapy (ART) guidelines, the South
African STG-EML, and the South African clinical practice guidelines. Currently, screening for smoking in primary
care settings is low and delivery of smoking cessation interventions even lower. Effective strategies to support
smoking cessation among PWH are necessary to reduce the burden of HIV- and smoking-associated
comorbidities. We have found that social and interpersonal stressors and difficulty managing cravings are
barriers to cessation among PWH who smoke in South Africa. Interventions developed for low-resourced settings
often address these proximal predictors and mediators of cessation, and can be easily adapted for South Africa,
provided they result in meaningful smoking abstinence rates and are feasible to implement. We will evaluate four
evidence-based smoking cessation interventions that address these identified challenges: (1) intensive
behavioral counseling, (2) peer counseling, (3) combination nicotine replacement therapy, and (4) varenicline.
Intervention development is guided by the Multiphase Optimization Treatment Strategy (MOST), a framework
for developing, optimizing, and evaluating interventions with consideration of time and financial resources, as
well as feasibility of implementation and cost. During this optimization phase of MOST, our first aim will evaluate
the main and interaction effects of these interventions among PWH. The second aim will characterize
implementation determinants of delivery of these smoking cessation interventions using the Reach,
Effectiveness, Adoptions, Implementation, Maintenance (RE-AIM) framework to inform scale-up and
sustainability. The third aim will compare the costs, cost-effectiveness, and budget impact of smoking cessation
interventions implemented as a routine program. Results will inform the development of a smoking cessation
treatment package optimized for PWH engaged in the South African HIV program.
项目摘要/摘要
本项目的目的是通过评估,
循证戒烟干预的有效性、实施和成本效益,
在其他低资源环境中取得了成功。南非有750万艾滋病毒感染者,
占全球负担的近20%。南非也是结核病年发病率最高的国家之一
在全球范围内(520/100,000),心血管疾病和慢性阻塞性肺疾病的负担日益加重
疾病(COPD)。吸烟是结核病的危险因素,而结核病是导致威尔斯亲王医院病人死亡的主要原因。此外,威尔斯亲王医院在
其他吸烟相关疾病的风险较高,包括心血管疾病和肺部合并症,
除了TB。在南非,吸烟是多产的;我们发现,52%的男性和13%的女性,
艾滋病毒是目前吸烟者。南非政策支持筛查吸烟和戒烟工作
这些都包括在南非国家抗逆转录病毒疗法(ART)指南中,南
非洲STG-EML和南非临床实践指南。目前,小学吸烟筛查
护理环境的水平很低,戒烟干预措施的提供甚至更低。有效的支持战略
为减低爱滋病病毒感染及吸烟引致的负担,
合并症。我们发现,社会和人际压力以及难以管理的渴望是
在南非,PWH吸烟者戒烟的障碍。为资源匮乏环境制定的干预措施
经常解决这些近端的预测和调解的停止,并可以很容易地适应南非,
只要它们能产生有意义的戒烟率,并且实施起来可行。我们将评估四个
基于证据的戒烟干预措施,以解决这些确定的挑战:(1)密集
行为咨询,(2)同伴咨询,(3)尼古丁替代疗法,和(4)伐尼克兰。
干预措施的制定由多阶段优化治疗策略(MOST)指导,
开发、优化和评估干预措施,同时考虑时间和财政资源,
以及实施的可行性和成本。在MOST的优化阶段,我们的第一个目标是评估
这些干预措施在PWH中的主要作用和相互作用。第二个目标将描述
使用Reach提供这些戒烟干预措施的实施决定因素,
有效性、采用、实施、维护(RE-AIM)框架,为扩大规模和
持续发展第三个目标将比较戒烟的成本、成本效益和预算影响
作为常规项目实施的干预措施。结果将告知戒烟的发展
为参与南非艾滋病毒项目的PWH优化的治疗包。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JONATHAN E. GOLUB其他文献
JONATHAN E. GOLUB的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JONATHAN E. GOLUB', 18)}}的其他基金
TB PuRe : Pulmonary rehabilitation to reduce post-tuberculosis morbidity
TB PuRe :肺康复可降低结核病后发病率
- 批准号:
10586385 - 财政年份:2023
- 资助金额:
$ 67.35万 - 项目类别:
PREVINE-TB: PRevent: EValuating the implementation of NEw strategies for preventive TB among people living with HIV in Brazil
PREVINE-TB:预防:评估巴西艾滋病毒感染者预防结核病新战略的实施情况
- 批准号:
10179305 - 财政年份:2018
- 资助金额:
$ 67.35万 - 项目类别:
PREVINE-TB: PRevent: EValuating the implementation of NEw strategies for preventive TB among people living with HIV in Brazil
PREVINE-TB:预防:评估巴西艾滋病毒感染者预防结核病新战略的实施情况
- 批准号:
10426171 - 财政年份:2018
- 资助金额:
$ 67.35万 - 项目类别:
Quantiferon Gold Test for Detecting TB Infection in HIV/AIDS Patients in Brazil
用于检测巴西艾滋病毒/艾滋病患者结核感染的 Quantiferon Gold 检测
- 批准号:
8843075 - 财政年份:2013
- 资助金额:
$ 67.35万 - 项目类别:
The Impact of Diabetes on TB treatment outcomes
糖尿病对结核病治疗结果的影响
- 批准号:
8607116 - 财政年份:2013
- 资助金额:
$ 67.35万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 67.35万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 67.35万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 67.35万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 67.35万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 67.35万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 67.35万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 67.35万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 67.35万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 67.35万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 67.35万 - 项目类别:
Research Grant